{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:03:37Z","timestamp":1790471017801,"version":"4.1.0"},"reference-count":84,"publisher":"Frontline Medical Communications, Inc.","issue":"2","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cutaneous Medicine and Surgery"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.sder.2009.04.001","type":"journal-article","created":{"date-parts":[[2009,7,15]],"date-time":"2009-07-15T05:00:05Z","timestamp":1247634005000},"page":"77-85","source":"Crossref","is-referenced-by-count":149,"title":["Management of Hyperpigmentation in Darker Racial Ethnic Groups"],"prefix":"10.12788","volume":"28","author":[{"given":"Pearl E.","family":"Grimes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5043","reference":[{"key":"10.1016\/j.sder.2009.04.001_bib1","first-page":"388","article-title":"Incidence of common dermatoses in a predominantly black dermatologic practice","volume":"32","author":"Halder","year":"1983","journal-title":"Cutis"},{"key":"10.1016\/j.sder.2009.04.001_bib2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0733-8635(03)00087-1","article-title":"Cutaneous diseases in Latinos","volume":"21","author":"Sanchez","year":"2003","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.sder.2009.04.001_bib3","first-page":"387","article-title":"Common dermatologic disorders of skin of colour; a comparative practice survey","volume":"80","author":"Alexis","year":"2007","journal-title":"Cutis"},{"key":"10.1016\/j.sder.2009.04.001_bib4","doi-asserted-by":"crossref","unstructured":"Balkrishnan R, McMichael AJ, Camacho FT, et al: Development and validation of a health-related quality of life instrument for women with melasma. The British Journal of Dermatology, 149:572-577.","DOI":"10.1046\/j.1365-2133.2003.05419.x"},{"key":"10.1016\/j.sder.2009.04.001_bib5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1473-2165.2008.00384.x","article-title":"Prevalence of pigmentary disorders and their impact on quality of life: A prospective cohort study","volume":"7","author":"Taylor","year":"2008","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0190-9622(97)70210-X","article-title":"Development and validation of a quality of life instrument for cutaneous diseases","volume":"37","author":"Anderson","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF02737863","article-title":"Measurement properties of Skindex-16: A brief quality-of-life measure for patients with skin diseases","volume":"5","author":"Chren","year":"2001","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.sder.2009.04.001_bib8","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1365-2133.2003.05419.x","article-title":"Development and validation of a health-related quality of life instrument for women with Melasma","volume":"149","author":"Balkrishnan","year":"2003","journal-title":"Br J Dermatol"},{"issue":"suppl 1","key":"10.1016\/j.sder.2009.04.001_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2133.2006.07591.x","article-title":"Validation of a Melasma quality of life questionnaire for Brazilian Portuguese language: The MelasQoL-BP study and improvement of QoL of Melasma patients after triple combination therapy","volume":"156","author":"Cestari","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib10","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0190-9622(81)70071-9","article-title":"Melasma: A clinical, light microscopic, ultrastructural, and immunofluorescence study","volume":"4","author":"Sanchez","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib11","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/1523-1747.ep12522896","article-title":"Endocrinologic profile of patients with idiopathic melasma","volume":"81","author":"P\u00e9rez","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1210\/jcem-61-1-28","article-title":"Association of melasma with thyroid autoimmunity and other thyroid abnormalities and their relationship to the origin of melasma","volume":"61","author":"Lufti","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.sder.2009.04.001_bib13","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1365-2133.2006.07179.x","article-title":"The dermal stem cell factor and c-kit are overexpressed in melasma","volume":"154","author":"Kang","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib14","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.0022-202X.2004.22503.x","article-title":"The epidermal stem cell factor is over-expressed in lentigo Senilis: Implication for the mechanism of hyperpigmentation","volume":"122","author":"Hattori","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.dad.0000154419.18653.2e","article-title":"Light microscopic, immunohistochemical and ultrastructural alterations in patients with melasma","volume":"27","author":"Grimes","year":"2005","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.sder.2009.04.001_bib16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1600-0749.1992.tb00562.x","article-title":"Melanocyte-stimulating properties of arachidonic acid metabolites: Possible role in postinflammatory pigmentation","volume":"5","author":"Tomita","year":"1992","journal-title":"Pig Cell Res"},{"issue":"suppl 41","key":"10.1016\/j.sder.2009.04.001_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2133.1992.tb16987.x","article-title":"Retinoic acid and pigment cells: A review of in in-vitro and in-vivo studies","volume":"127","author":"Ortonne","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1034\/j.1600-0749.2003.00029.x","article-title":"Chemical and instrumental approaches to treat hyperpigmentation","volume":"16","author":"Briganti","year":"2003","journal-title":"Pig Cell Res"},{"key":"10.1016\/j.sder.2009.04.001_bib19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1396-0296.2004.04015.x","article-title":"Management of dyschromias in ethnic skin","volume":"17","author":"Halder","year":"2004","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.sder.2009.04.001_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-4165(91)90186-K","article-title":"Mechanism of inhibition of melanogenesis by hydroquinone","volume":"1073","author":"Palumbo","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.sder.2009.04.001_bib21","first-page":"83A","article-title":"Evaluation of clinical and light microscopic effects of various concentrations of hydroquinone","volume":"39","author":"Glenn","year":"1991","journal-title":"Clin Res"},{"key":"10.1016\/j.sder.2009.04.001_bib22","first-page":"58","article-title":"Double-blind comparison of azelaic acid and hydroquinone in the treatment of Melasma","volume":"143","author":"Verallo-Rowell","year":"1989","journal-title":"Acta Derm Venereol Supplementum (Stockh)"},{"key":"10.1016\/j.sder.2009.04.001_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1524-4725.2000.99233.x","article-title":"Efficacy of hydroquinone cream (USP 4%) Used alone or in combination with salicylic acid peels in improving photodamage on the neck and upper chest","volume":"26","author":"Gladstone","year":"2000","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.sder.2009.04.001_bib24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/1076-0512(96)00065-9","article-title":"The combination of glycolic acid and hydroquinone or kojic acid for the treatment of Melasma and related conditions","volume":"22","author":"Garcia","year":"1996","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.sder.2009.04.001_bib25","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1365-4632.2003.02017.x","article-title":"Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid antioxidants, and sunscreen in the treatment of melasma","volume":"l42","author":"Guevara","year":"2003","journal-title":"Int J Dermato"},{"key":"10.1016\/j.sder.2009.04.001_bib26","first-page":"67","article-title":"Efficacy and safety of a new triple-combination agent for the treatment of facial melasma","volume":"72","author":"Taylor","year":"2003","journal-title":"Cutis"},{"key":"10.1016\/j.sder.2009.04.001_bib27","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1001\/archderm.138.12.1578","article-title":"Efficacy of glycolic acid peels in the treatment of melasma","volume":"138","author":"Hurley","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib28","first-page":"239","article-title":"Topical tretinoin, hydroquinone and betamethasone valerate in the therapy of melasma","volume":"23","author":"Gano","year":"1979","journal-title":"Cutis"},{"key":"10.1016\/j.sder.2009.04.001_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00128071-200607040-00003","article-title":"A comprehensive review of the long-term and short-term treatment of melasma with a triple combination cream","volume":"7","author":"Torok","year":"2006","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib30","first-page":"57","article-title":"Hydroquinone, 4%, tretinoin, 0.05%, fluocinolone acetonide, 0.01%: A safe and efficacious 12-month treatment for Melasma","volume":"75","author":"Torok","year":"2005","journal-title":"Cutis"},{"key":"10.1016\/j.sder.2009.04.001_bib31","first-page":"697","article-title":"A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide, 0.01%, hydroquinone, 4%, tretinoin, 0.05%) compared with hydroquinone, 4% cream in Asian patients with moderate to severe Melasma","volume":"159","author":"Chan","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib32","first-page":"177","article-title":"Community-based trial of a triple-combination agent for the treatment of facial melasma","volume":"77","author":"Grimes","year":"2006","journal-title":"Cutis"},{"key":"10.1016\/j.sder.2009.04.001_bib33","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1468-3083.1997.tb00238.x","article-title":"N-acetylcysteine as a bleaching agent in the treatment of melasma","volume":"9","author":"Njoo","year":"1997","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.sder.2009.04.001_bib34","first-page":"362","article-title":"A microsponge formulation of hydroquinone, 4% and retinol, 0.15% in the treatment of melasma and postinflammatory hyperpigmentation","volume":"74","author":"Grimes","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.sder.2009.04.001_bib35","first-page":"497","article-title":"An efficacy study of 3 commercially available hydroquinone, 4% treatments for melasma","volume":"80","author":"Grimes","year":"2007","journal-title":"Cutis"},{"key":"10.1016\/j.sder.2009.04.001_bib36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/archderm.1961.01580130137022","article-title":"Hydroquinone bleaching","volume":"84","author":"Spencer","year":"1961","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib37","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/archderm.1995.01690240119022","article-title":"Etiologic and therapeutic considerations","volume":"131","author":"Grimes","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/10408449991349221","article-title":"The toxicology of hydroquinone\u2014Relevance to occupational and environmental exposure","volume":"29","author":"DeCaprio","year":"1999","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.sder.2009.04.001_bib39","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2133.1975.tb05110.x","article-title":"Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams","volume":"93","author":"Findlay","year":"1975","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib40","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0190-9622(83)80022-X","article-title":"Localized exogenous ochronosis","volume":"8","author":"Cullison","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib41","first-page":"229","article-title":"Exogenous ochronosis: An epidemiological study","volume":"12","author":"Hardwick","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1001\/archderm.1985.01660010109032","article-title":"Ochronosis-like pigmentation from hydroquinone bleaching creams in American Blacks","volume":"121","author":"Hoshaw","year":"1985","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib43","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0190-9622(88)70126-7","article-title":"Exogenous ochronosis in the United States","volume":"18","author":"Lawrence","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2165\/00128071-200102040-00002","article-title":"Exogenous ochronosis","volume":"2","author":"Levin","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00000372-198602000-00003","article-title":"Ochronosis in Black South Africans who used skin lighteners","volume":"8","author":"Phillips","year":"1986","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.sder.2009.04.001_bib46","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0278-6915(92)90075-V","article-title":"Toxicity and carcinogenicity of hydroquinone in F344\/N rats and B6C3F1 mice","volume":"30","author":"Kari","year":"1992","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.sder.2009.04.001_bib47","unstructured":"Hydroquinone IARC Monogr Eval Carcinog Risks Hum 71:691-719, 1999"},{"key":"10.1016\/j.sder.2009.04.001_bib48","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0190-9622(00)90219-6","article-title":"The combination of 2% 4-hydroxyanisole (mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies","volume":"42","author":"Fleischer","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"suppl 2","key":"10.1016\/j.sder.2009.04.001_bib49","first-page":"6","article-title":"Postinflammatory hyperpigmentation: Evolving combination treatment strategies","volume":"78","author":"Taylor","year":"2006","journal-title":"Cutis"},{"key":"10.1016\/j.sder.2009.04.001_bib50","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1473-2165.2007.00321.x","article-title":"Hyperpigmentation and melasma","volume":"6","author":"Rigopoulos","year":"2007","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-4362.1995.tb03583.x","article-title":"Azelaic acid: Pharmacokinetic and pharmacodynamic properties and its therapeutic role in hyperpigmentary disorders and acne","volume":"34","author":"Nguyen","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib52","first-page":"893","article-title":"The treatment of melasma","volume":"30","author":"Beli\u00f1a","year":"1991","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib53","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0149-2918(98)80076-3","article-title":"Azelaic acid, 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients","volume":"20","author":"Lowe","year":"1998","journal-title":"Clin Ther"},{"key":"10.1016\/j.sder.2009.04.001_bib54","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0149-2918(98)80077-5","article-title":"Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: A clinical comparison with hydroquinone","volume":"20","author":"Kakita","year":"1998","journal-title":"Clin Ther"},{"key":"10.1016\/j.sder.2009.04.001_bib55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000065851","article-title":"A comparative study of 20% azelaic acid cream monotherapy versus a sequential therapy in the treatment of melasma in dark-skinned patients","volume":"205","author":"Sarkar","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.sder.2009.04.001_bib56","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1524-4725.1999.08236.x","article-title":"Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid","volume":"25","author":"Lim","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.sder.2009.04.001_bib57","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1529-8019.2007.00144.x","article-title":"Skin lightening preparations and the hydroquinone controversy","volume":"20","author":"Draelos","year":"2007","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.sder.2009.04.001_bib58","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-0749.1998.tb00494.x","article-title":"The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation","volume":"11","author":"Yokota","year":"1989","journal-title":"Pig Cell Res"},{"key":"10.1016\/j.sder.2009.04.001_bib59","series-title":"Anti-Inflammatory properties of licochalone A from Glycyrrhiza inflate in various human skin cells","author":"Dieck","year":"2005"},{"key":"10.1016\/j.sder.2009.04.001_bib60","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00403-006-0654-4","article-title":"Anti-inflammatory efficacy of Licochalcone A: Correlation of clinical potency and in vitro effects","volume":"298","author":"Kolbe","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.sder.2009.04.001_bib61","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-4362.2000.00943.x","article-title":"Topical liquiritin improves Melasma","volume":"39","author":"Amer","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib62","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0022-3565(25)12357-4","article-title":"Arbutin: Mechanism of its depigmenting action in human melanocyte culture","volume":"276","author":"Maeda","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"issue":"suppl","key":"10.1016\/j.sder.2009.04.001_bib63","first-page":"48","article-title":"Adapalene gel 0.1% for topical treatment of acne vulgaris in African patients","volume":"68","author":"Jacyk","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.sder.2009.04.001_bib64","first-page":"45","article-title":"Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin","volume":"77","author":"Grimes","year":"2006","journal-title":"Cutis"},{"key":"10.1016\/j.sder.2009.04.001_bib65","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0190-9622(96)90830-0","article-title":"Inhibitory effect of magnesium L-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo","volume":"34","author":"Kameyama","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib66","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1523-1747.2001.01291.x","article-title":"An alternative approach to depigmentation by soybean extracts via inhibition of the PAR-2 pathway","volume":"116","author":"Paine","year":"2001","journal-title":"J Invest Dermatol"},{"issue":"suppl","key":"10.1016\/j.sder.2009.04.001_bib67","first-page":"2","article-title":"Natural considerations for skin of color","volume":"78","author":"Baumann","year":"2006","journal-title":"Cutis"},{"key":"10.1016\/j.sder.2009.04.001_bib68","first-page":"917","article-title":"Efficacy of a soy moisturizer in photoaging: A double-blind, vehicle-controlled, 12-week study","volume":"6","author":"Wallo","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib69","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1473-2165.2006.00277.x","article-title":"Glucosamine: An ingredient with skin and other benefits","volume":"5","author":"Bissett","year":"2006","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib70","first-page":"373","article-title":"Topical N-acetyl glucosamine affects pigmentation relevant genes in in vitro genomics testing","volume":"19","author":"Bissett","year":"2006","journal-title":"Pig Cell Res"},{"key":"10.1016\/j.sder.2009.04.001_bib71","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1365-2133.2002.04834.x","article-title":"The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer","volume":"147","author":"Hakozaki","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib72","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ptr.1537","article-title":"Oral intake of proanthocyanidin-rich extract from grape seeds improves chloasma","volume":"18","author":"Yamakoshi","year":"2004","journal-title":"Phytother Res"},{"key":"10.1016\/j.sder.2009.04.001_bib73","first-page":"154","article-title":"Superficial chemical peels, In Grimes PE (ed): Aesthetics and Cosmetic Surgery for Darker Skin Types","author":"Grimes","year":"2008"},{"issue":"suppl 2","key":"10.1016\/j.sder.2009.04.001_bib74","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1016\/j.jaad.2005.12.039","article-title":"Treatment of melasma","volume":"54","author":"Rendon","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib75","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1046\/j.1365-4362.2001.01149.x","article-title":"Safety and efficacy of glycolic acid facial peel in Indian women with melasma","volume":"40","author":"Javaheri","year":"2001","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.sder.2009.04.001_bib76","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1076-0512(97)00056-3","article-title":"Glycolic acid peels for post-inflammatory hyperpigmentation in black patients: A comparative study","volume":"23","author":"Burns","year":"1997","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.sder.2009.04.001_bib77","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1524-4725.2004.30106.x","article-title":"Efficacy of hydroquinone, 2% versus tretinoin, 0.025% as adjunct topical agents for chemical peeling in patients of melasma","volume":"30","author":"Nanda","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.sder.2009.04.001_bib78","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1524-4725.1999.08145.x","article-title":"The safety and efficacy of salicylic acid chemical peels in darker racial ethnic groups","volume":"25","author":"Grimes","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.sder.2009.04.001_bib79","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1524-4725.1993.tb00360.x","article-title":"Benign pigmented lesions of the skin","volume":"19","author":"Goldberg","year":"1993","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1016\/j.sder.2009.04.001_bib80","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1524-4725.1994.tb00152.x","article-title":"Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q-switched ruby laser","volume":"20","author":"Taylor","year":"1994","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1016\/j.sder.2009.04.001_bib81","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1524-4725.2003.29009.x","article-title":"Combined ultrapulse CO2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma: Split-face design","volume":"29","author":"Angsuwarangsee","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.sder.2009.04.001_bib82","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1524-4725.1999.08103.x","article-title":"Erbium: YAG laser resurfacing for refractory melasma","volume":"25","author":"Manaloto","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.sder.2009.04.001_bib83","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1524-4725.1993.tb00361.x","article-title":"510-nm pigmented lesion dye laser","volume":"19","author":"Grekin","year":"1993","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1016\/j.sder.2009.04.001_bib84","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2310\/6350.2005.31302","article-title":"The treatment of melasma with fractional photothermolysis: A pilot study","volume":"31","author":"Rokhsar","year":"2005","journal-title":"Dermatol Surg"}],"container-title":["Seminars in Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S108556290900025X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S108556290900025X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scmsjournal.com\/wp-content\/uploads\/2016\/01\/Vol28_i2-Hyperpigmentation.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T20:40:38Z","timestamp":1739220038000},"score":1,"resource":{"primary":{"URL":"http:\/\/scmsjournal.com\/article\/buy_now\/?id=242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S108556290900025X"],"URL":"https:\/\/doi.org\/10.1016\/j.sder.2009.04.001","relation":{},"ISSN":["1085-5629"],"issn-type":[{"value":"1085-5629","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}